Lincoln Pharmaceuticals Ltd. has been awarded a Patent for “An Arteether Injection For Treatment of Malaria”, Patent No.258915 by Government of India for Antimalarial Drug. In the present time, this formulation, “Arteether !njection”are available in market in 3ml and 2ml ampoules form. At the time of injecting “Arteether Injection” to the patient by doctors , it is very painful for a long time. Patient will have to take this injection at least for a period of three days to control the malaria.
Total Antimalarial market in African Countries are estimated Rs.586 Crores. Presently Lincoln Pharma is exporting nearly Rs.50 Crores Antimalarial Products to African Countries. With introduction of this new “Arteether Injection” in African countries, company expect to increase additional Rs.35 Crore to Rs.40 Crore revenue in the coming years.
Lincoln Pharma have in house R & D facilities since 2000. Company has developed many new drug delivery dosages forms over a period of time. Recently , company has developed a new Novel Drug Delivery System (HDDS) “ An Arteether Injection for Treatment of Malaria”.
Lincoln Pharma’s R & D Research team has developed a painless Injection with compressed dosage form by reducing inside drug material up to 50% volume. This new“Arteether Injection” developed by our company is available in 1 ml only. Due to this new innovation, patient will get faster relief and painless. The results of this new “Arteether Injection” are far better than the other existing dosages form are available in the market.
